Biote

Irving, United States Founded: 2011 • Age: 15 yrs
Hormone replacement and pellet therapy services are offered.
Annual revenue $197.2M Latest available
Total funding - Funding intelligence
Employees 217 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About Biote

Biote is a company based in Irving (United States) founded in 2011 by Gary Donovitz. The company has 217 employees as of December 31, 2024. Biote offers products and services including Pellet Therapy and BHRT. Biote operates in a competitive market with competitors including Amazentis, DecodeAge, Timeline, Nuchido and Ponce De Leon Health, among others.

  • Headquarter Irving, United States
  • Employees 217 as on 31 Dec, 2024
  • Founders Gary Donovitz
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Biote Corp.
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $197.19 M (USD)
    6.38
    as on Dec 31, 2024
  • Net Profit
    $3.16 M (USD)
    -4.79
    as on Dec 31, 2024
  • EBITDA
    $44.96 M (USD)
    -2.71
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    217

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Biote

Biote is a publicly listed company on the NASDAQ with ticker symbol BTMD in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: BTMD · Sector: Health services · USA

Products & Services of Biote

Biote offers a comprehensive portfolio of products and services, including Pellet Therapy and BHRT.

Product name locked
Category locked
Primary

Method for inserting hormones to optimize patient levels

Product name locked
Category locked
Locked

Bioidentical therapy to address imbalance symptoms

People of Biote

Headcount 50-200
Employee Profiles 50
Board Members and Advisors 6
Employee Profiles
People
Kami Deike
District Manager- Las Vegas And Utah
People
Joey Lopes
Senior Vice President, Strategy And Commercial Operations
People
Bob Peterson
Chief Financial Officer
People
Haley Edwards
District Manager

Unlock access to complete

Board Members and Advisors
people
Marc Beer
Executive Chairman
people
Debra Morris
Board Member
people
Andrew R. Heyer
Board Member
people
Dana Jacoby
Board Member

Unlock access to complete

Funding Insights of Biote

Premium access

Detailed funding history for Biote

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biote

Investments
Premium access

Investment portfolio details for Biote

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Biote

Premium access

Detailed financials for Biote

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biote Comparisons

Biote Primary company
Description
Hormone replacement and pellet therapy services are offered.
Location
Irving, United States
Founded Year
2011
Annual Revenue
$197.19 M (USD)
Net Profit
$3.16 M (USD)
EBITDA
$44.96 M (USD)
Employees
217
As of 2024
Premium access

Peer comparison for Biote

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Biote

Biote operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amazentis, DecodeAge, Timeline, Nuchido and Ponce De Leon Health, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developing nutritional products to slow aging and improve quality of life
Locked Locked Locked
Online platform offering drugs for longevity and age health
Locked Locked Locked
Clinically-tested Urolithin A supplements and skincare are developed.
Locked Locked Locked
Manufacturer of dietary supplements
Locked Locked Locked
Anti-aging nutraceutical supplements are developed and tested.
Premium access

Detailed competitors of Biote

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biote

Premium access

Complete news archive for Biote

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biote

Biote was founded in 2011.

Biote is headquartered in Irving, United States. It is registered at Irving, Texas, United States.

Terry Weber is the current CEO of Biote.

As of Dec 31, 2024, the latest employee count at Biote is 217.

Annual revenue of Biote is $197.19M as on Dec 31, 2024.

Biote was founded in 2011 and is headquartered in Irving, United States. Operations focus on the healthcare sector, specifically hormone replacement therapy and bioidentical pellet insertions. Services are delivered through a network of practitioners, targeting hormone optimization for patients. Leadership includes founder Gary Donovitz and CEO Terry Weber, with activities centered in the U.S. market.

Biote's top competitors include Timeline, DecodeAge and Amazentis.

Biote offers Pellet Therapy and BHRT.

Yes, Biote is publicly traded on NASDAQ under the ticker symbol BTMD.

The ticker symbol of Biote is BTMD on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available